Atossa Therapeutics, Inc.
ATOS · NASDAQ
Market closed$2.49$0.100000 (+4.18%)After hours $2.45 · -1.61%
Key statistics
Previous close$2.39
Open$2.34
Day high$2.49
Day low$2.27
52-week high$19.35
52-week low$1.70
Market cap21.44M
Volume47.48K
Average volume154.49K
P/E ratio-0.73
Forward P/E—
EPS-3.42
Dividend yield0.00%
Market context
Why it moved
ATOS shares moved higher as renewed interest in European technology sovereignty, highlighted by major companies like Airbus shifting sensitive data away from US cloud providers, boosted sentiment toward European IT firms like Atos.
What is happening
Recent company-specific developments and publisher coverage.
Simply Wall Street · June 25, 2026Atossa Therapeutics, Inc. (NASDAQ:ATOS): Are Analysts Optimistic?PR Newswire · June 12, 2026Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross ProceedsTradingView · June 11, 2026Atossa Therapeutics Prices Registered Direct Offering at $3.30, Netting About $4.1 MillionStock Titan · June 11, 2026Biotech Atossa targets up to $16.5M to fund clinical workInvesting.com · June 11, 2026Atossa Therapeutics stock tumbles on $4.5M stock offeringPR Newswire · May 27, 2026Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 TrialPR Newswire · May 8, 2026Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate UpdateStocktwits · May 4, 2026ATOS Stock Jumps 8% Today – An FDA Designation Draws Investor Cheer For Atossa Therapeutics